Comparison of Prasugrel and Ticagrelor Loading Doses in ST-Segment Elevation Myocardial Infarction Patients
Top Cited Papers
- 22 March 2013
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 61 (15), 1601-1606
- https://doi.org/10.1016/j.jacc.2013.01.024
Abstract
No abstract availableFunding Information
- Bayer
- Boehringer Ingelheim
- Pfizer
This publication has 12 references indexed in Scilit:
- ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevationEuropean Heart Journal, 2012
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and InterventionsJournal of the American College of Cardiology, 2011
- High on-thienopyridine platelet reactivity in elderly coronary patients: the SENIOR-PLATELET studyEuropean Heart Journal, 2011
- Residual Platelet Reactivity, Bleedings, and Adherence to Treatment in Patients Having Coronary Stent Implantation Treated With PrasugrelThe American Journal of Cardiology, 2011
- The effect of ticagrelor versus clopidogrel on high on-treatment platelet reactivity: Combined analysis of the ONSET/OFFSET and RESPOND studiesAmerican Heart Journal, 2011
- Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes: The PLATO (PLATelet inhibition and patient Outcomes) PLATELET SubstudyJournal of the American College of Cardiology, 2010
- Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trialEuropean Heart Journal, 2009
- Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations inP2RY12, P2RY1,andITGB3Platelets, 2009
- Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery diseaseEuropean Heart Journal, 2006
- Platelet inhibitory activity and pharmacokinetics of prasugrel (CS-747) a novel thienopyridine P2Y12 inhibitor: A multiple-dose study in healthy humansPlatelets, 2006